Advertisement
Australia markets close in 4 hours 28 minutes
  • ALL ORDS

    8,068.50
    +3.00 (+0.04%)
     
  • ASX 200

    7,796.30
    +3.00 (+0.04%)
     
  • AUD/USD

    0.6576
    -0.0025 (-0.37%)
     
  • OIL

    78.09
    -0.29 (-0.37%)
     
  • GOLD

    2,317.40
    -6.80 (-0.29%)
     
  • Bitcoin AUD

    95,157.52
    -1,981.95 (-2.04%)
     
  • CMC Crypto 200

    1,297.45
    -67.68 (-4.96%)
     
  • AUD/EUR

    0.6118
    -0.0013 (-0.21%)
     
  • AUD/NZD

    1.0982
    -0.0006 (-0.05%)
     
  • NZX 50

    11,794.08
    -6.70 (-0.06%)
     
  • NASDAQ

    18,091.45
    -2.12 (-0.01%)
     
  • FTSE

    8,313.67
    +100.18 (+1.22%)
     
  • Dow Jones

    38,884.26
    +31.99 (+0.08%)
     
  • DAX

    18,430.05
    +254.84 (+1.40%)
     
  • Hang Seng

    18,510.54
    +31.17 (+0.17%)
     
  • NIKKEI 225

    38,432.48
    -402.62 (-1.04%)
     

Eastman Chemical (EMN) Reports Q1 Earnings: What Key Metrics Have to Say

For the quarter ended March 2024, Eastman Chemical (EMN) reported revenue of $2.31 billion, down 4.2% over the same period last year. EPS came in at $1.61, compared to $1.63 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $2.26 billion, representing a surprise of +2.25%. The company delivered an EPS surprise of +14.18%, with the consensus EPS estimate being $1.41.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Eastman Chemical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net Sales- Advanced Materials: $748 million compared to the $729.05 million average estimate based on five analysts. The reported number represents a change of +0.8% year over year.

  • Net Sales- Additives & Functional Products: $704 million compared to the $709.43 million average estimate based on five analysts. The reported number represents a change of -9.4% year over year.

  • Net Sales- Chemical Intermediates: $523 million versus $499.86 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -11.2% change.

  • Net Sales- Fibers: $331 million versus the five-analyst average estimate of $321.81 million. The reported number represents a year-over-year change of +9.2%.

  • Net Sales- Other: $4 million versus $2 million estimated by two analysts on average.

  • Adjusted EBIT- Additives & Functional Products: $109 million versus $89.65 million estimated by five analysts on average.

  • Adjusted EBIT- Advanced Materials: $104 million compared to the $95.92 million average estimate based on five analysts.

  • Adjusted EBIT- Chemical Intermediates: $16 million versus the five-analyst average estimate of $22.90 million.

  • Adjusted EBIT- Other: -$72 million compared to the -$56 million average estimate based on five analysts.

  • Adjusted EBIT- Fibers: $117 million versus $103.51 million estimated by five analysts on average.

View all Key Company Metrics for Eastman Chemical here>>>

Shares of Eastman Chemical have returned -3.2% over the past month versus the Zacks S&P 500 composite's -3% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Eastman Chemical Company (EMN) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research